D. David Meek
Affiliations
- at Cullinan Therapeutics Inc. (CGEM), 2025-06-16
- Director at Uniqure N.v. (QURE), 2025-06-13
- at Fusion Pharmaceuticals Inc. (FUSN), 2024-06-04
- Chief Executive Officer at Mirati Therapeutics Inc. (MRTX), 2023-01-24
- Director at Entasis Therapeutics Holdings Inc. (ETTX), 2022-07-11
- Evp And President, Oncology at Baxalta Inc (BXLT), 2016-06-07
- Chief Commercial Officer at Endocyte Inc (ECYT), 2014-02-10
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| QURE | $5.12 | 2,229 | $11,412.48 | 20,252 | 2024-06-13 | Filing |
| QURE | $18.85 | 2,290 | $43,166.50 | 22,481 | 2023-06-16 | Filing |
| QURE | $19.71 | 389 | $7,667.19 | 16,071 | 2023-02-27 | Filing |
| MRTX | $42.38 | 3,179 | $134,714.58 | 61,792 | 2023-01-17 | Filing |
| MRTX | $40.41 | 4,616 | $186,551.95 | 64,971 | 2022-12-21 | Filing |